# Cumberland Pharmaceuticals Inc: Form DEF 14A, filed Mar 16, 2017

- Company: [Cumberland Pharmaceuticals Inc](/companies/cpix.md) (CIK 1087294)
- Form: DEF 14A
- Filed: 2017-03-16
- Accepted by EDGAR: Mar 16, 2017, 17:07 ET
- Period: 2017-04-25
- Accession: 0001628280-17-002649
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1087294/000162828017002649/a2017proxystatement.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1087294/000162828017002649/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1087294/000162828017002649/a2017proxystatement.htm

Filed Mar 16, 2017.
Source: SEC EDGAR, the filing index for accession 0001628280-17-002649. Last ingested by Listed: Nov 11, 2026, 03:05 ET. No prices; not investment advice.